/cloudfront-eu-central-1.images.arcpublishing.com/prisa/V2NAVI42Y5AOVERJYN2OAZN3V4.jpg)
Covid vaccines: From having too few to having too many
European countries are negotiating with pharmaceutical companies to avoid accumulating unused doses
European countries are negotiating with pharmaceutical companies to avoid accumulating unused doses
The pharmaceutical giant said Monday that it will pay $229 per Seagen share
The company accuses its competitors of copying its messenger RNA technology without its permission